111, Inc. income statement

In fiscal 2025, 111, Inc. reported revenue of $1.75bn, down 12.7% on the year before, operating income of −$330,753 (a -0.0% margin) and net income of −$9.2m, or −$1.06 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

111, Inc.: income statement, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	132	142	271	572	1,189	1,926	2,013	2,113	2,002	1,747
Cost of revenue	—	8	11	548	1,136	1,830	1,888	1,993	1,886	1,646
Gross profit	11	12	16	24	53	96	125	120	115	101
Selling and marketing	38	28	39	49	58	80	68	63	44	36
General and administrative	9	8	15	18	19	32	31	32	10	10
Operating income	−55	−38	−61	−71	−69	−100	−55	−49	0	−0
Interest expense	0	0	—	1	1	1	2	3	4	5
Provision for credit losses	—	—	—	0	0	0	0	0	0	0
Income before tax	−55	−37	−58	−73	−68	−96	−56	−50	−3	−3
Income tax	—	—	0	0	0	0	0	0	0	0
Net income	−55	−37	−58	−72	−66	−104	−62	−55	−9	−9
Diluted EPS	—	−$10.22	−$11.58	−$8.83	−$8.03	−$12.53	−$7.45	−$6.59	−$1.06	−$1.06
Diluted shares (average)	4m	4m	5m	8m	8m	8m	8m	8m	9m	9m
EBITDA	−53	−35	−59	−70	−67	−95	−49	−46	3	1

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HSIC vs YI COSM vs YI HKPD vs YI COR vs YI

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from 111, Inc.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to 111, Inc.